Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis

Infection

Volumn 25, Issue 2, 1997, Pages 106-108

  Smith, A ^a,b   Weber, A ^a,b,c   Pandher, R ^a,b   Williams Warren, J ^a,b   Cohen, M L ^a,b   Ramsey, B ^a,b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DEVELOPING COUNTRY; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG MONITORING; DRUG SALIVA LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RELIABILITY; SALMONELLOSIS; SHIGELLOSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CYSTIC FIBROSIS; DRUG COMPOUNDING; DRUG MONITORING; HUMANS; PSEUDOMONAS INFECTIONS; REGRESSION ANALYSIS; SALIVA; SALIVARY GLANDS;

EID: 0031004190     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02113587     Document Type: Article

References (13)

1. Davis, R. L., Koup, J. R., Williams-Warren, J., Weber, A., Heggen, L., Stempel, D., Smith, A. L.: Pharmacokinetics of ciprofloxacin in cystic fibrosis. Antimicrob. Agents Chemother. 31 (1987) 915-919.
2. Sörgel, F., Naber, K. G., Kinzig, M., Mahr, G., Muth, P.: Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review. Am. J. Med. 30 (1991) 51S-66S.
3. LeBel, M.: Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 316-324.
4. Sörgel, F., Stephan, U., Wiesemann, H. G., Gottschalk, B., Stehr, C., Rey, M., Bowing, H. B., Dominick, H. C., Geldmacher von Mallinckrodt, M.: High dose treatment with antibiotics in cystic fibrosis - a reappraisal with special reference to the pharmacokinetics of betalactams and new fluoroquinolones in adult CF-patients. Infection 15 (1987) 385-396.
5. Peltola, H., Vaarala, M., Renkonen, O.-V., Neuvonen, P. J.: Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrob. Agents Chemother. 36 (1992) 1086-1090.
6. Schaefer, H. G., Stass, H., Wedgwood, J., Hampel, B., Fischer, C, Kuhlmann, J., Schaad, U. B.: Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients. Antimicrob. Agents Chemother. 40 (1996) 29-34.
7. Adam, D., Rubio, T. T.: The use of new quinolones in pediatric medicine. FAC Fortschritte der Antimikrobiellen Antineoplastischen Chemotherapie (1992) 11-12.
8. Pertuiset, E., Menkes, C. J., Lenoir, G., Jehanne, M., Douchain, F., Guillot, M.: Cystic fibrosis arthritis. A report of five cases. Br. J. Rheumatol. 31 (1992) 535-538.
9. Gardiner, P. V., Roberts, S. D., Bell, A. L.: Cystic fibrosis and rheumatoid arthritis. Br. J. Rheumatol. 28 (1989) 179.
10. Weber, A., Chaffin, D., Smith, A., Opheim, K. E.: Quantitation of ciprofloxacin in body fluids by high pressure liquid chromatography. Antimicrob. Agents Chemother. 27 (1985) 531-535.
11. Aronoff, G. E., Kenner, C. H., Sloan, R. S., Pottratz, S. T.: Multiple-dose ciprofloxacin kinetics in normal subjects. Clin. Pharmacol. Ther. 36 (1984) 384-388.
12. LeBel, M., Bergeron, M. G., Valle'e, F., Fiset, C., Chasse', G., Bigonesse, P., Rivard, G.: Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients. Antimicrob. Agents Chemother. 30 (1986) 260-266.
13. Rocci, M. L., Jr., Jusko, W. J.: LAGRAN program for area and moments in pharmacokinetic analysis. Comp. Progr. in Biomed. 16 (1983) 203-216.